MedTrace Logo

Blood Hpercoagublity in Copd

NCT05380960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-05-19

No results posted yet for this study

Summary

"The objective of this study is to evaluate the blood coagulability state in patients with COPD admitted at Assiut University Hospital"

Conditions

  • Blood Coagulability in Copd

Interventions

DEVICE

cbc coaglation profile

The Demographic, clinical, and laboratory data for the enrolled subjects will be collected. To assess the coagulability state in the participants, we will measure the levels of certain markers in the blood that are thought to be associated with an increased coagulability. A comparison will be made between the different included groups regarding the level of these markers. These markers included complete blood count (CBC) indices (hematocrit, red cell distribution width, platelets count, mean platelet volume and platelet distribution width), C - reactive protein, d dimer, and blood coagulation tests (prothrombin time, international normalized ratio and partial thromboplastin time).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-09-01
Completion
2023-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05380960 on ClinicalTrials.gov